Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-036796

Chief Accounting Officer sold 5,045 shares at $5.64 ($28,453)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-09 Sale : show line 1 in the form −5,045 $5.64 $28,453 129,512 D
Open-market sales · 5,045 sh · avg $5.64 · $28,453
Loading xslF345X04/doc4.xml…